Catherine Caillaud

5.7k total citations · 1 hit paper
107 papers, 3.6k citations indexed

About

Catherine Caillaud is a scholar working on Physiology, Rheumatology and Epidemiology. According to data from OpenAlex, Catherine Caillaud has authored 107 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Physiology, 34 papers in Rheumatology and 29 papers in Epidemiology. Recurrent topics in Catherine Caillaud's work include Lysosomal Storage Disorders Research (81 papers), Glycogen Storage Diseases and Myoclonus (29 papers) and Carbohydrate Chemistry and Synthesis (24 papers). Catherine Caillaud is often cited by papers focused on Lysosomal Storage Disorders Research (81 papers), Glycogen Storage Diseases and Myoclonus (29 papers) and Carbohydrate Chemistry and Synthesis (24 papers). Catherine Caillaud collaborates with scholars based in France, United States and Tunisia. Catherine Caillaud's co-authors include Livia Poënaru, Axel Kahn, Saïd Akli, Michel Perricaudet, Emmanuelle Vigne, Roseline Froissart, Leslie D. Stratford-Perricaudet, Marc Peschanski, Thierry Levade and Thierry Billette de Villemeur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Catherine Caillaud

107 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

2017 510 citations Jérôme Stirnemann, Nadia Belmatoug et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Caillaud France	32	2.1k	1.5k	803	789	712	107	3.6k
Anna‐Elina Lehesjoki Finland	39	1.4k 0.7×	2.1k 1.4×	943 1.2×	1.6k 2.0×	1.0k 1.5×	126	4.9k
Annick Raas‐Rothschild Israel	34	982 0.5×	1.7k 1.1×	781 1.0×	898 1.1×	146 0.2×	108	3.8k
Mary E. LaMarca United States	19	1.5k 0.7×	1.0k 0.7×	966 1.2×	267 0.3×	248 0.3×	28	2.6k
Livia Poënaru France	26	1.1k 0.5×	1.0k 0.7×	285 0.4×	576 0.7×	296 0.4×	86	2.1k
Brian Bigger United Kingdom	35	1.7k 0.8×	1.3k 0.9×	617 0.8×	567 0.7×	246 0.3×	115	3.5k
Donna M. Krasnewich United States	28	671 0.3×	1.3k 0.9×	488 0.6×	362 0.5×	142 0.2×	59	2.4k
Jaana Tyynelä Finland	31	1.7k 0.8×	1.4k 1.0×	1.1k 1.4×	138 0.2×	213 0.3×	63	3.1k
Jill A. Morris United States	23	1.1k 0.5×	1.4k 1.0×	720 0.9×	367 0.5×	130 0.2×	41	2.9k
A. T. Hoogeveen Netherlands	29	848 0.4×	1.9k 1.3×	399 0.5×	1.2k 1.5×	175 0.2×	80	3.0k
Nahid Tayebi United States	32	2.6k 1.2×	1.0k 0.7×	1.8k 2.3×	195 0.2×	208 0.3×	74	4.1k

Countries citing papers authored by Catherine Caillaud

Since Specialization

Citations

This map shows the geographic impact of Catherine Caillaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Caillaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Caillaud more than expected).

Fields of papers citing papers by Catherine Caillaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Caillaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Caillaud. The network helps show where Catherine Caillaud may publish in the future.

Co-authorship network of co-authors of Catherine Caillaud

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Caillaud. A scholar is included among the top collaborators of Catherine Caillaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Caillaud. Catherine Caillaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brassier, Anaïs, Samia Pichard, Manuel Schiff, et al.. (2023). Motor outcomes in patients with infantile and juvenile Pompe disease: Lessons from neurophysiological findings. Molecular Genetics and Metabolism. 139(4). 107650–107650. 1 indexed citations

Chartier, Suzanne, Lucile Boutaud, Caroline Alby, et al.. (2021). Prenatal‐onset of congenital neuronal ceroid lipofuscinosis with a novel CTSD mutation. Birth Defects Research. 113(18). 1324–1332. 2 indexed citations

Masingue, Marion, Timothée Lenglet, Cyril Goizet, et al.. (2020). Natural History of Adult Patients with GM2 Gangliosidosis. Annals of Neurology. 87(4). 609–617. 41 indexed citations

Hordeaux, Juliette, Laurence Dubreil, Johan Deniaud, et al.. (2017). Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease. Acta Neuropathologica Communications. 5(1). 66–66. 48 indexed citations

Lecourt, Séverine, Enguerran Mouly, Audrey Cras, et al.. (2013). A Prospective Study of Bone Marrow Hematopoietic and Mesenchymal Stem Cells in Type 1 Gaucher Disease Patients. PLoS ONE. 8(7). e69293–e69293. 27 indexed citations

Chabrol, B., Catherine Caillaud, & Berge A. Minassian. (2013). Neuronal ceroid lipofuscinoses. Handbook of clinical neurology. 113. 1701–1706. 14 indexed citations

Lecourt, Séverine, Valérie Vanneaux, Audrey Cras, et al.. (2011). Bone Marrow Microenvironment in an In Vitro Model of Gaucher Disease: Consequences of Glucocerebrosidase Deficiency. Stem Cells and Development. 21(2). 239–248. 26 indexed citations

Héron, Bénédicte, Yann Mikaeloff, Roseline Froissart, et al.. (2010). Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. American Journal of Medical Genetics Part A. 155(1). 58–68. 128 indexed citations

Berger, Juliette, Séverine Lecourt, Valérie Vanneaux, et al.. (2010). Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease. British Journal of Haematology. 150(1). 93–101. 26 indexed citations

10.

Sedel, Frédéric, Catherine Caillaud, Roseline Froissart, et al.. (2010). A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients. Brain and Development. 33(2). 131–139. 32 indexed citations

11.

Douillard‐Guilloux, Gaëlle, Nina Raben, Shoichi Takikita, et al.. (2009). Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe disease. Human Molecular Genetics. 19(4). 684–696. 49 indexed citations

12.

Autefage, Hélène, Virginie Garcia, Hortense Bergès, et al.. (2009). Lysosomal Serine Protease CLN2 Regulates Tumor Necrosis Factor-α-mediated Apoptosis in a Bid-dependent Manner. Journal of Biological Chemistry. 284(17). 11507–11516. 18 indexed citations

13.

Douillard‐Guilloux, Gaëlle, et al.. (2009). Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of α‐glucosidase in Pompe disease. The Journal of Gene Medicine. 11(4). 279–287. 31 indexed citations

14.

Laforêt, Pascal, Valérie Doppler, Catherine Caillaud, et al.. (2009). Rigid spine syndrome revealing late-onset Pompe disease. Neuromuscular Disorders. 20(2). 128–130. 26 indexed citations

15.

Turkia, Hadhami Ben, et al.. (2009). Phenotypic continuum of type 2 Gaucher's disease: an intermediate phenotype between perinatal-lethal and classic type 2 Gaucher's disease. Journal of Perinatology. 29(2). 170–172. 12 indexed citations

16.

Turkia, Hadhami Ben, Néji Tebib, Olga Amaral, et al.. (2007). [Mutation spectrum of Gaucher disease in Tunisia: high frequency of N370S/Rec NciI compound heterozygous].. PubMed. 84(1-4). 65–70. 5 indexed citations

17.

Caillaud, Catherine. (2007). Diagnostic des maladies lysosomiales. La Revue de Médecine Interne. 28. S288–S289. 1 indexed citations

18.

Díaz, George A., Bruce D. Gelb, Neil Risch, et al.. (2000). Gaucher Disease: The Origins of the Ashkenazi Jewish N370S and 84GG Acid β-Glucosidase Mutations. The American Journal of Human Genetics. 66(6). 1821–1832. 52 indexed citations

19.

Letourneur, Franck, et al.. (1997). Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene. Human Mutation. 9(3). 234–242. 21 indexed citations

20.

Caillaud, Catherine, Françoise Rey, Philippe Labrune, et al.. (1991). Spectrum of phenylketonuria mutations in Western Europe and North Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine hydroxylase locus. Human Genetics. 86(4). 355–358. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact